Clinical Trials
2 trialsNCT00312013 2017-03-23
Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer
GlaxoSmithKline
Phase 3 Completed
NCT00951574 2012-02-01
Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)
Italfarmaco
Phase 3 Completed